Wide Ranks

AMRN

Amarin Corporation plc

0.4920

Top Statistics
Market Cap 202 M Forward PE -2.24 Revenue Growth -36.00 %
Current Ratio 3.23 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -16.33 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 2.33 Enterprise / Revenue -0.3950 Price To Sales Trailing12 Months 0.8397
Profitability
Profit Margins -16.33 % Operating Margins -59.50 %
Balance Sheet
Total Cash 305 M Total Cash Per Share 0.7430 Total Debt 8 M
Total Debt To Equity 1.55 Current Ratio 3.23 Book Value Per Share 1.29
All Measures
Short Ratio 1649.00 % Message Board Id finmb_407863 Shares Short Prior Month 18 M
Return On Equity -0.0726 City Dublin Uuid c9af6797-92a0-34d5-9138-8aac9b223625
Previous Close 0.4996 First Trade Date Epoch Utc 733 M Book Value 1.29
Beta 1.93 Total Debt 8 M Volume 1 M
Price To Book 0.3808 Last Split Date 1 B Fifty Two Week Low 0.4600
Total Cash Per Share 0.7430 Total Revenue 241 M Shares Short Previous Month Date 1 B
Target Median Price 1.00 Max Age 86400 Recommendation Mean 3.67
Sand P52 Week Change 0.3133 Operating Margins -59.50 % Target Mean Price 1.00
Net Income To Common -39346000 Short Percent Of Float 0.0441 Implied Shares Outstanding 426 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 1 M
Average Volume10days 1 M Total Cash 305 M Next Fiscal Year End 1 B
Revenue Per Share 0.5880 Held Percent Insiders 0.0160 Ebitda Margins -16.96 %
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 0.4996 Target Low Price 1.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 0.5708 Open 0.4996 Free Cashflow -17890876
Dividend Yield 0.00 % Return On Assets -0.0345 Time Zone Short Name EST
Trailing Eps -0.1000 Day Low 0.4822 Address1 Iconic Offices, The Greenway
Shares Outstanding 411 M Price Hint 4 Target High Price 1.00
Website https://www.amarincorp.com 52 Week Change -0.3718 Average Volume 980906
Forward Eps -0.2100 Recommendation Key underperform Compensation As Of Epoch Date 1 B
Quick Ratio 207.60 % Last Split Factor 1:10 Regular Market Day High 0.5144
Is_sp_500 False Profit Margins -16.33 % Debt To Equity 1.55
Fifty Two Week High 1.37 Day High 0.5144 Shares Short 17 M
Regular Market Open 0.4996 Industry Key drug-manufacturers-general Earnings Growth 0.00 %
Enterprise To Revenue -0.3950 Revenue Growth -36.00 % Shares Percent Shares Out 0.0436
Operating Cashflow -18355000 Currency USD Time Zone Full Name America/New_York
Market Cap 202 M Is_nasdaq_100 False Zip 112-114
Quote Type EQUITY Industry Drug Manufacturers - General Long Name Amarin Corporation plc
Regular Market Day Low 0.4822 Held Percent Institutions 0.1705 Current Price 0.4920
Address2 Block C Ardilaun Court St Stephens Green Enterprise To Ebitda 2.33 Financial Currency USD
Current Ratio 3.23 Gross Margins 56.46 % Industry Disp Drug Manufacturers - General
Number Of Analyst Opinions 2 Country Ireland Float Shares 383 M
Two Hundred Day Average 0.7582 Ir Website http://investor.amarincorp.com/ Enterprise Value -95138640
Price To Sales Trailing12 Months 0.8397 Forward PE -2.24 Regular Market Volume 1 M
Ebitda -40873000 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates.

The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia.

It sells its products principally to wholesalers and specialty pharmacy providers.

The company has a collaboration with Mochida Pharmaceutical Co.

, Ltd.

to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa.

The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999.

Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.